Cynthia X. Ma, MD, PhD, Washington University School of Medicine in St. Louis, St. Louis, MO, outlines key developments in the treatment of breast cancer expected in 2021, including the use of immune checkpoint inhibitors in the neoadjuvant setting of patients with triple negative breast cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).